2024 News

Novoprotein Linkdin News

NOVOPROTEIN

NOVOPROTEIN SCIENTIFIC , the mRNA reagent materials and recombinant proteins supplier from China. Novoprotein provides a one-stop solution of mRNA raw materials and services to support mRNA vaccines research and development. Our products include restriction enzymes, T7 RNA Polymerase, RNase inhibitor, Pyrophosphatase, DNaseI, Nucleotides, Vaccinia Capping Enzyme, mRNA 2´-O-Methyltransferase, Poly(A) Polymerase, RNase R, etc. The manufacturing processes are strictly controlled to ensure the products are animal-free and ampicillin-free. We guarantee the manufacturing and quality control comply with GMP regulation for tracking each step of the manufacturing process, including raw material sourcing.

 

2024/06/06
Exciting news from Innorna! On June 5, 2024, Innorna announced that its independently developed RSV bivalent mRNA vaccine, IND for IN006, received approval from the CDE. This achievement follows the January 2024 IND approval from the US Food and Drug Administration (FDA).

#Biotech #Vaccines #RSV #mRNA #Moderna #NOVOPROTEIN

Congratulations to Innorna's world's first bivalent RSV mRNA vaccine, IND for IN006, approved by CDE in China!
LinkedIn 上的NOVOPROTEIN


News 

You can connect with us by following Novoprotein Linedin

 

Products Finding

Gene and Cell Therapy. Cytokines. Target Protein. mRNA Vaccine & Drug Enzymes. Immuno-Diagnostics Reagents. Biosimilar Reference Antibodies

Technology and Learning

You can get the Technology on our websites